🇺🇸 FDA
Patent

US 11925611

Use of ZT-1A and analogs thereof to prevent and/or treat neurodegenerative and neurocognitive disorders

granted A61KA61K31/167A61P

Quick answer

US patent 11925611 (Use of ZT-1A and analogs thereof to prevent and/or treat neurodegenerative and neurocognitive disorders) held by United States Government as represented by the Department of Veterans Affairs expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/167, A61P, A61P25/28